Local stimulation of articular cartilage repair by transplantation of encapsulated chondrocytes overexpressing human fibroblast growth factor 2 (FGF-2) in vivo

Gunter Kaul, Magali Cucchiarini, David Arntzen, David Zurakowski, Michael D. Menger, Dieter Kohn, Stephen Trippel, Henning Madry

Research output: Contribution to journalArticle

81 Citations (Scopus)

Abstract

Background: Defects of articular cartilage are an unsolved problem in orthopaedics. In the present study, we tested the hypothesis that gene transfer of human fibroblast growth factor 2 (FGF-2) via transplantation of encapsulated genetically modified articular chondrocytes stimulates chondrogenesis in cartilage defects in vivo. Methods: Lapine articular c hondrocytes overexpressing a lacZ or a human FGF-2 gene sequence were encapsulated in alginate and further characterized. The resulting lacZ or FGF-2 spheres were applied to cartilage defects in the knee joints of rabbits. In vivo, cartilage repair was assessed qualitatively and quantitatively at 3 and 14 weeks after implantation. Results: In vitro, bioactive FGF-2 was secreted, leading to a significant increase in the cell numbers in FGF-2 spheres. In vivo, FGF-2 continued to be expressed for at least 3 weeks without leading to differences in FGF-2 concentrations in the synovial fluid between treatment groups. Histological analysis revealed no adverse pathologic effects on the synovial membrane at any time point. FGF-2 gene transfer enhanced type II collagen expression and individual parameters of chondrogenesis, such as the cell morphology and architecture of the new tissue. Overall articular cartilage repair was significantly improved at both time points in vivo. Conclusions: The data suggest that localized overexpression of FGF-2 enhances the repair of cartilage defects via stimulation of chondrogenesis, without adverse effects on the synovial membrane. These results may lead to the development of safe gene-based therapies for human articular cartilage defects.

Original languageEnglish
Pages (from-to)100-111
Number of pages12
JournalJournal of Gene Medicine
Volume8
Issue number1
DOIs
StatePublished - Jan 2006

Fingerprint

Articular Cartilage
Fibroblast Growth Factor 2
Chondrocytes
Transplantation
Chondrogenesis
Cartilage
Synovial Membrane
Joints
Genes
Collagen Type II
Synovial Fluid
Knee Joint
Genetic Therapy
Orthopedics
Cell Count
Rabbits

Keywords

  • Alginate
  • Cartilage defects
  • Chondrocytes
  • FGF-2
  • Transfection
  • Transplantation

ASJC Scopus subject areas

  • Genetics

Cite this

Local stimulation of articular cartilage repair by transplantation of encapsulated chondrocytes overexpressing human fibroblast growth factor 2 (FGF-2) in vivo. / Kaul, Gunter; Cucchiarini, Magali; Arntzen, David; Zurakowski, David; Menger, Michael D.; Kohn, Dieter; Trippel, Stephen; Madry, Henning.

In: Journal of Gene Medicine, Vol. 8, No. 1, 01.2006, p. 100-111.

Research output: Contribution to journalArticle

Kaul, Gunter ; Cucchiarini, Magali ; Arntzen, David ; Zurakowski, David ; Menger, Michael D. ; Kohn, Dieter ; Trippel, Stephen ; Madry, Henning. / Local stimulation of articular cartilage repair by transplantation of encapsulated chondrocytes overexpressing human fibroblast growth factor 2 (FGF-2) in vivo. In: Journal of Gene Medicine. 2006 ; Vol. 8, No. 1. pp. 100-111.
@article{277ca509b54142aeaccb6d843e51233b,
title = "Local stimulation of articular cartilage repair by transplantation of encapsulated chondrocytes overexpressing human fibroblast growth factor 2 (FGF-2) in vivo",
abstract = "Background: Defects of articular cartilage are an unsolved problem in orthopaedics. In the present study, we tested the hypothesis that gene transfer of human fibroblast growth factor 2 (FGF-2) via transplantation of encapsulated genetically modified articular chondrocytes stimulates chondrogenesis in cartilage defects in vivo. Methods: Lapine articular c hondrocytes overexpressing a lacZ or a human FGF-2 gene sequence were encapsulated in alginate and further characterized. The resulting lacZ or FGF-2 spheres were applied to cartilage defects in the knee joints of rabbits. In vivo, cartilage repair was assessed qualitatively and quantitatively at 3 and 14 weeks after implantation. Results: In vitro, bioactive FGF-2 was secreted, leading to a significant increase in the cell numbers in FGF-2 spheres. In vivo, FGF-2 continued to be expressed for at least 3 weeks without leading to differences in FGF-2 concentrations in the synovial fluid between treatment groups. Histological analysis revealed no adverse pathologic effects on the synovial membrane at any time point. FGF-2 gene transfer enhanced type II collagen expression and individual parameters of chondrogenesis, such as the cell morphology and architecture of the new tissue. Overall articular cartilage repair was significantly improved at both time points in vivo. Conclusions: The data suggest that localized overexpression of FGF-2 enhances the repair of cartilage defects via stimulation of chondrogenesis, without adverse effects on the synovial membrane. These results may lead to the development of safe gene-based therapies for human articular cartilage defects.",
keywords = "Alginate, Cartilage defects, Chondrocytes, FGF-2, Transfection, Transplantation",
author = "Gunter Kaul and Magali Cucchiarini and David Arntzen and David Zurakowski and Menger, {Michael D.} and Dieter Kohn and Stephen Trippel and Henning Madry",
year = "2006",
month = "1",
doi = "10.1002/jgm.819",
language = "English",
volume = "8",
pages = "100--111",
journal = "Journal of Gene Medicine",
issn = "1099-498X",
publisher = "John Wiley and Sons Ltd",
number = "1",

}

TY - JOUR

T1 - Local stimulation of articular cartilage repair by transplantation of encapsulated chondrocytes overexpressing human fibroblast growth factor 2 (FGF-2) in vivo

AU - Kaul, Gunter

AU - Cucchiarini, Magali

AU - Arntzen, David

AU - Zurakowski, David

AU - Menger, Michael D.

AU - Kohn, Dieter

AU - Trippel, Stephen

AU - Madry, Henning

PY - 2006/1

Y1 - 2006/1

N2 - Background: Defects of articular cartilage are an unsolved problem in orthopaedics. In the present study, we tested the hypothesis that gene transfer of human fibroblast growth factor 2 (FGF-2) via transplantation of encapsulated genetically modified articular chondrocytes stimulates chondrogenesis in cartilage defects in vivo. Methods: Lapine articular c hondrocytes overexpressing a lacZ or a human FGF-2 gene sequence were encapsulated in alginate and further characterized. The resulting lacZ or FGF-2 spheres were applied to cartilage defects in the knee joints of rabbits. In vivo, cartilage repair was assessed qualitatively and quantitatively at 3 and 14 weeks after implantation. Results: In vitro, bioactive FGF-2 was secreted, leading to a significant increase in the cell numbers in FGF-2 spheres. In vivo, FGF-2 continued to be expressed for at least 3 weeks without leading to differences in FGF-2 concentrations in the synovial fluid between treatment groups. Histological analysis revealed no adverse pathologic effects on the synovial membrane at any time point. FGF-2 gene transfer enhanced type II collagen expression and individual parameters of chondrogenesis, such as the cell morphology and architecture of the new tissue. Overall articular cartilage repair was significantly improved at both time points in vivo. Conclusions: The data suggest that localized overexpression of FGF-2 enhances the repair of cartilage defects via stimulation of chondrogenesis, without adverse effects on the synovial membrane. These results may lead to the development of safe gene-based therapies for human articular cartilage defects.

AB - Background: Defects of articular cartilage are an unsolved problem in orthopaedics. In the present study, we tested the hypothesis that gene transfer of human fibroblast growth factor 2 (FGF-2) via transplantation of encapsulated genetically modified articular chondrocytes stimulates chondrogenesis in cartilage defects in vivo. Methods: Lapine articular c hondrocytes overexpressing a lacZ or a human FGF-2 gene sequence were encapsulated in alginate and further characterized. The resulting lacZ or FGF-2 spheres were applied to cartilage defects in the knee joints of rabbits. In vivo, cartilage repair was assessed qualitatively and quantitatively at 3 and 14 weeks after implantation. Results: In vitro, bioactive FGF-2 was secreted, leading to a significant increase in the cell numbers in FGF-2 spheres. In vivo, FGF-2 continued to be expressed for at least 3 weeks without leading to differences in FGF-2 concentrations in the synovial fluid between treatment groups. Histological analysis revealed no adverse pathologic effects on the synovial membrane at any time point. FGF-2 gene transfer enhanced type II collagen expression and individual parameters of chondrogenesis, such as the cell morphology and architecture of the new tissue. Overall articular cartilage repair was significantly improved at both time points in vivo. Conclusions: The data suggest that localized overexpression of FGF-2 enhances the repair of cartilage defects via stimulation of chondrogenesis, without adverse effects on the synovial membrane. These results may lead to the development of safe gene-based therapies for human articular cartilage defects.

KW - Alginate

KW - Cartilage defects

KW - Chondrocytes

KW - FGF-2

KW - Transfection

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=31644440253&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=31644440253&partnerID=8YFLogxK

U2 - 10.1002/jgm.819

DO - 10.1002/jgm.819

M3 - Article

C2 - 16097039

AN - SCOPUS:31644440253

VL - 8

SP - 100

EP - 111

JO - Journal of Gene Medicine

JF - Journal of Gene Medicine

SN - 1099-498X

IS - 1

ER -